{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:21:29Z","timestamp":1792178489690,"version":"4.4.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 UM1AI126617-01"],"award-info":[{"award-number":["1 UM1AI126617-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1P01 CA225618-01A1"],"award-info":[{"award-number":["1P01 CA225618-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01 HL132791-01"],"award-info":[{"award-number":["1R01 HL132791-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23-HL136783-01"],"award-info":[{"award-number":["K23-HL136783-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA148600-07-304 A1"],"award-info":[{"award-number":["P01 CA148600-07-304 A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2020.00298","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T06:10:34Z","timestamp":1594102234000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Virus-Specific T Cell Therapies for HIV: Lessons Learned From Hematopoietic Stem Cell Transplantation"],"prefix":"10.3389","volume":"10","author":[{"given":"Ping-Hsien","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Bollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19859","DOI":"10.7448\/IAS.17.1.19859","article-title":"The transient HIV remission in the mississippi baby: why is this good news?","volume":"17","author":"Ananworanich","year":"2014","journal-title":"J. Int. AIDS Soc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9523","DOI":"10.1073\/pnas.1120248109","article-title":"Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection","volume":"109","author":"Archin","year":"","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11904-018-0382-3","article-title":"The role of integrin \u03b14\u03b27 in HIV pathogenesis and treatment","volume":"15","author":"Arthos","year":"2018","journal-title":"Curr. HIV\/AIDS Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"a007161","DOI":"10.1101\/cshperspect.a007161","article-title":"HIV-1 antiretroviral drug therapy","volume":"2","author":"Arts","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"Berger","year":"2008","journal-title":"J. Clin. Invest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1200\/JCO.2012.43.5784","article-title":"Improving T-cell therapy for epstein-barr virus lymphoproliferative disorders","volume":"31","author":"Bollard","year":"2013","journal-title":"J. Clin. Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1093\/infdis\/jix005","article-title":"Perspectives on human immunodeficiency virus (HIV) cure: HIV persistence in tissue","volume":"215","author":"Boritz","year":"2017","journal-title":"J. Infect. Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/4716","article-title":"In vivo migration and function of transferred HIV-1-specific cytotoxic T cells","volume":"5","author":"Brodie","year":"1999","journal-title":"Nat. Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1182\/blood-2006-03-011791","article-title":"Marked increased risk of epstein-barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation","volume":"108","author":"Brunstein","year":"2006","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"197ra103","DOI":"10.1126\/scitranslmed.3006034","article-title":"Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells","volume":"5","author":"Cameron","year":"2013","journal-title":"Sci. Transl. Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1182\/blood-2010-11-320226","article-title":"HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo","volume":"117","author":"Chapuis","year":"2011","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/44755","article-title":"Re-emergence of HIV after stopping therapy","volume":"401","author":"Chun","year":"1999","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/nm1295-1284","article-title":"In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency","volume":"1","author":"Chun","year":"1995","journal-title":"Nat. Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0198158","DOI":"10.1371\/journal.pone.0198158","article-title":"An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients","volume":"13","author":"Colston","year":"2018","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3109\/14653241003709686","article-title":"Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience","volume":"12","author":"Cruz","year":"2010","journal-title":"Cytotherapy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1182\/blood-2013-06-506741","article-title":"Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study","volume":"122","author":"Cruz","year":"2013","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1002251","DOI":"10.1371\/journal.pbio.1002251","article-title":"Extremely high mutation rate of HIV-1 in vivo","volume":"13","author":"Cuevas","year":"2015","journal-title":"PLoS Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1002461","DOI":"10.1371\/journal.pmed.1002461","article-title":"Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: a case study","volume":"14","author":"Cummins","year":"2017","journal-title":"PLoS Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/cid\/cis613","article-title":"The rising challenge of non-AIDS-defining cancers in HIV-infected patients","volume":"55","author":"Deeken","year":"2012","journal-title":"Clin. Infect. Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/487439a","article-title":"HIV: shock and kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11904-017-0359-7","article-title":"The lymph node in HIV pathogenesis","volume":"14","author":"Dimopoulos","year":"2017","journal-title":"Curr. HIV\/AIDS Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/imr.12131","article-title":"Design and development of therapies using chimeric antigen receptor-expressing T cells","volume":"257","author":"Dotti","year":"2014","journal-title":"Immunol. Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","article-title":"Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation","volume":"119","author":"Doubrovina","year":"2012","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1016\/S2352-3018(15)00083-1","article-title":"CCR5 Delta32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report","volume":"2","author":"Duarte","year":"2015","journal-title":"Lancet HIV"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat. Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1016\/S2352-3018(20)30069-2","article-title":"Evidence for HIV-1 cure after CCR5\u039432\/\u039432 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report","volume":"7","author":"Gupta","year":"2020","journal-title":"Lancet HIV"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.7326\/M14-1027","article-title":"Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases","volume":"161","author":"Henrich","year":"2014","journal-title":"Ann. Intern. Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/infdis\/jit086","article-title":"Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation","volume":"207","author":"Henrich","year":"2013","journal-title":"J. Infect. Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"B34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4049\/jimmunol.142.2.452","article-title":"Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans","volume":"142","author":"Hoffenbach","year":"1989","journal-title":"J. Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3389\/fimmu.2017.01272","article-title":"Virus-specific T cells for the immunocompromised patient","volume":"8","author":"Houghtelin","year":"2017","journal-title":"Front. Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1056\/NEJMc1412279","article-title":"More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32\/delta32 mutation","volume":"371","author":"Hutter","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N. Engl. J. Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13045-019-0701-1","article-title":"Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation","volume":"12","author":"Kaeuferle","year":"2019","journal-title":"J. Hematol. Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.3389\/fimmu.2019.02310","article-title":"CAR talk: how cancer-specific CAR T cells can instruct how to build CAR T cells to cure HIV","volume":"10","author":"Kim","year":"2019","journal-title":"Front. Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1073\/pnas.0503726102","article-title":"Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells","volume":"102","author":"Klebanoff","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B41","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/QAI.0000000000001381","article-title":"Impact of allogeneic hematopoietic stem cell transplantation on the HIV reservoir and immune response in 3 HIV-infected individuals","volume":"75","author":"Koelsch","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B42","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nm0495-330","article-title":"Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression","volume":"1","author":"Koenig","year":"1995","journal-title":"Nat. Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1056\/NEJMc1405805","article-title":"Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation","volume":"371","author":"Kordelas","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0065-2776(06)90008-X","article-title":"Checkpoint blockade in cancer immunotherapy","volume":"90","author":"Korman","year":"2006","journal-title":"Adv. Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"Koup","year":"1994","journal-title":"J. Virol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/COH.0000000000000088","article-title":"Coinhibitory receptors and CD8 T cell exhaustion in chronic infections","volume":"9","author":"Kuchroo","year":"2014","journal-title":"Curr. Opin. HIV AIDS"},{"key":"B47","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/COH.0000000000000485","article-title":"Chimeric antigen receptor T-cell approaches to HIV cure","volume":"13","author":"Kuhlmann","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"B48","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/mt.2014.207","article-title":"Broadly-specific cytotoxic T cells targeting multiple HIV antigens are expanded from HIV+ patients: implications for immunotherapy","volume":"23","author":"Lam","year":"2015","journal-title":"Mol. Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"422","DOI":"10.20411\/pai.v2i3.226","article-title":"Ten years HIV free: an interview with \u201cthe berlin patient,\u201d timothy ray brown","volume":"2","author":"Lederman","year":"2017","journal-title":"Pathog Immun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat. Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1182\/blood.V90.6.2196","article-title":"Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients","volume":"90","author":"Lieberman","year":"1997","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"key":"B54","first-page":"190","article-title":"A multi-step pace towards a cure for HIV: kick, kill, and contain","volume":"15","author":"Lopez","year":"2013","journal-title":"AIDS Rev"},{"key":"B55","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/MOT.0b013e32834016b9","article-title":"T-cell therapy for cytomegalovirus infection","volume":"15","author":"Mui","year":"2010","journal-title":"Curr. Opin. Organ Transplant"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/sj.bmt.1705164","article-title":"Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath)","volume":"36","author":"Myers","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3389\/fimmu.2019.02109","article-title":"Toward T cell-mediated control or elimination of HIV reservoirs: lessons from cancer immunology","volume":"10","author":"Mylvaganam","year":"2019","journal-title":"Front. Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/mt.2016.3","article-title":"Novel conserved-region T-cell mosaic vaccine with high global HIV-1 coverage is recognized by protective responses in untreated infection","volume":"24","author":"Ondondo","year":"2016","journal-title":"Mol. Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat epstein-barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N. Engl. J. Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.ymthe.2018.04.009","article-title":"HIV-Specific T cells generated from naive T cells suppress HIV in vitro and recognize wide epitope breadths","volume":"26","author":"Patel","year":"2018","journal-title":"Mol. Ther"},{"key":"B61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.omtm.2019.10.001","article-title":"HIV-specific T cells can be generated against non-escaped T cell epitopes with a GMP-compliant manufacturing platform","volume":"16","author":"Patel","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.bbmt.2015.12.007","article-title":"Functionally active HIV-specific T cells that target gag and nef can be expanded from virus-naive donors and target a range of viral epitopes: implications for a cure strategy after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Patel","year":"2016","journal-title":"Biol. Blood Marrow Transplant"},{"key":"B63","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fimmu.2020.00361","article-title":"Advances in developing CAR T-cell therapy for HIV cure","volume":"11","author":"Qi","year":"2020","journal-title":"Front. Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"B65","doi-asserted-by":"publisher","first-page":"ofy090","DOI":"10.1093\/ofid\/ofy090","article-title":"Transplantation of CCR532 homozygous umbilical cord blood in a child with acute lymphoblastic leukemia and perinatally acquired HIV infection","volume":"5","author":"Rothenberger","year":"2018","journal-title":"Open Forum Infect. Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1073\/pnas.0611244104","article-title":"Agence Nationale de Recherches sur le Sida, HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype","volume":"104","author":"Saez-Cirion","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B67","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcyt.2013.11.010","article-title":"The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care","volume":"16","author":"Saglio","year":"2014","journal-title":"Cytotherapy"},{"key":"B68","doi-asserted-by":"publisher","first-page":"674","DOI":"10.7326\/M18-0759","article-title":"Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant","volume":"169","author":"Salgado","year":"2018","journal-title":"Ann. Intern. Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.192.11.1553","article-title":"CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function","volume":"192","author":"Schaerli","year":"2000","journal-title":"J. Exp. Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"132ra53","DOI":"10.1126\/scitranslmed.3003761","article-title":"Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells","volume":"4","author":"Scholler","year":"2012","journal-title":"Sci. Transl. Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.immuni.2018.04.030","article-title":"Targeting the latent reservoir for HIV-1","volume":"48","author":"Sengupta","year":"2018","journal-title":"Immunity"},{"key":"B72","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41571-019-0184-6","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah","year":"2019","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","article-title":"Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation","volume":"36","author":"Shan","year":"2012","journal-title":"Immunity"},{"key":"B74","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.humimm.2017.10.001","article-title":"Frequencies of gene variant CCR5-Delta32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers","volume":"78","author":"Solloch","year":"2017","journal-title":"Hum. Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-med-052716-031710","article-title":"Novel Latency Reversal Agents for HIV-1 Cure","volume":"69","author":"Spivak","year":"2018","journal-title":"Annu. Rev. Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1086\/428777","article-title":"Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1","volume":"191","author":"Strain","year":"2005","journal-title":"J. Infect. Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2386187","DOI":"10.1155\/2018\/2386187","article-title":"Immunotherapy with CAR-modified T cells: toxicities and overcoming strategies","volume":"2018","author":"Sun","year":"2018","journal-title":"J. Immunol Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/infdis\/jiv022","article-title":"Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir","volume":"212","author":"Sung","year":"2015","journal-title":"J. Infect. Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.ymthe.2018.08.015","article-title":"HIV-specific, ex vivo expanded T cell therapy: feasibility, safety, and efficacy in ART-suppressed HIV-infected individuals","volume":"26","author":"Sung","year":"2018","journal-title":"Mol. Ther"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1182\/blood-2012-07-447250","article-title":"Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV","volume":"121","author":"Tebas","year":"2013","journal-title":"Blood"},{"key":"B81","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1016\/S2352-3018(19)30086-4","article-title":"Like London buses, two putative cure cases arrive at once","volume":"6","author":"The Lancet","year":"2019","journal-title":"Lancet HIV"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol. Blood Marrow Transplant"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/nm.1779","article-title":"Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor","volume":"14","author":"Varela-Rohena","year":"2008","journal-title":"Nat. Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11904-018-0388-x","article-title":"Quarter century of anti-HIV CAR T cells","volume":"15","author":"Wagner","year":"2018","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"B86","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/328345a0","article-title":"HIV-specific cytotoxic T lymphocytes in seropositive individuals","volume":"328","author":"Walker","year":"1987","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nri3478","article-title":"Unravelling the mechanisms of durable control of HIV-1","volume":"13","author":"Walker","year":"2013","journal-title":"Nat. Rev. Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov"},{"key":"B89","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1084\/jem.194.7.953","article-title":"Migratory properties of naive, effector, and memory CD8(+) T cells","volume":"194","author":"Weninger","year":"2001","journal-title":"J. Exp. Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","article-title":"CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia","volume":"381","author":"Xu","year":"2019","journal-title":"N. Engl. J. Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.3389\/fimmu.2018.02861","article-title":"Therapeutic targeting of HIV reservoirs: how to give T cells a new direction","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Immunol"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00298\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T15:20:06Z","timestamp":1696346406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00298\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":92,"alternative-id":["10.3389\/fcimb.2020.00298"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.00298","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]},"article-number":"298"}}